Clinical Trials Directory

Trials / Conditions / Metastatic Urothelial Cancer

Metastatic Urothelial Cancer

17 registered clinical trials studyying Metastatic Urothelial Cancer — 2 currently recruiting.

StatusTrialSponsorPhase
WithdrawnA Study of MFA-370 in Patients with Metastatic Urothelial Cancer
NCT05390645
Ectin Research ABPhase 1 / Phase 2
CompletedA Study of Real-world Treatment of Adults With Urothelial Cancer in South Korea and Saudi Arabia
NCT06505746
Astellas Pharma Singapore Pte. Ltd.—
Active Not RecruitingStudy BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
NCT06225596
BicycleTx LimitedPhase 2 / Phase 3
RecruitingClofarabine Therapy in Locally Advanced or Metastatic Urothelial Carcinoma
NCT07034053
Ekaterina LaukhtinaPhase 1 / Phase 2
Active Not RecruitingStudy of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors
NCT05101096
Gilead SciencesPhase 1 / Phase 2
CompletedA Study to Evaluate Enfortumab Vedotin (ASG-22CE) in Chinese Participants With Locally Advanced or Metastatic
NCT04995419
Astellas Pharma China, Inc.Phase 2
CompletedA Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)
NCT03679767
Incyte CorporationPhase 2
Active Not RecruitingStudy of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemothera
NCT03682068
AstraZenecaPhase 3
RecruitingStudy of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
NCT03547973
Gilead SciencesPhase 2
CompletedAvelumab Plus Carboplatin-gemcitabine in Urothelial Carcinoma
NCT03390595
Associació per a la Recerca Oncologica, SpainPhase 2
CompletedGemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Pat
NCT03451331
Matthew GalskyPhase 2
UnknownPaclitaxel and TAK-228 in Urothelial Carcinoma
NCT03745911
Associació per a la Recerca Oncologica, SpainPhase 2
CompletedTrial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations
NCT03448718
Matthew GalskyPhase 2
CompletedA Study of Enfortumab Vedotin in Japanese Subjects With Locally Advanced or Metastatic Urothelial Carcinoma
NCT03070990
Astellas Pharma IncPhase 1
CompletedTrial of Stereotactic Body Radiotherapy With Concurrent Pembrolizumab in Metastatic Urothelial Cancer
NCT02826564
University Hospital, GhentPhase 1
CompletedA Study Evaluating Chemotherapy With Fractionated Cisplatin/Gemcitabine Versus Carboplatin/Gemcitabine in the
NCT02240017
Institut Claudius RegaudPhase 2 / Phase 3
CompletedASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial
NCT01963052
Astellas Pharma Global Development, Inc.Phase 1